Charles Reinhart

Charles Reinhart

Director/Board Member at
Vectorlogics, Inc.
65 year
Health Technology
Consumer Services

Profile

Charles A. Reinhart currently works at Vectorlogics, Inc., as Director.
Mr. Reinhart also formerly worked at Osiris Therapeutics, Inc., as Independent Director from 2018 to 2019, Flexion Therapeutics, Inc., as Chief Financial Officer & Director, Cephalon, Inc., as Vice President-Finance in 2007, Millennium Pharmaceuticals, Inc., as Senior Vice President-Finance & Strategy in 2008, GenVec, Inc., as Principal, Delsys Pharmaceutical Corp., as Principal, Archimedes Pharma Ltd., as Chief Financial Officer & Executive Vice President from 2011 to 2014, PharmAthene, Inc., as Chief Financial Officer & Senior Vice President from 2009 to 2011, Covis Pharmaceuticals, Inc., as Chief Financial Officer from 2014 to 2015, and Pacira Biosciences, Inc., as Chief Financial Officer from 2016 to 2024.
Mr. Reinhart received his undergraduate degree in 1982 from Lehigh University and Masters Business Admin degree in 1990 from The Wharton School of the University of Pennsylvania.

Charles Reinhart active positions

CompaniesPositionStart
Director/Board Member 09/10/2009

Former positions of Charles Reinhart

CompaniesPositionEnd
PACIRA BIOSCIENCES, INC. Director of Finance/CFO 30/09/2024
OSIRIS THERAPEUTICS, INC. Director/Board Member 17/04/2019
Director of Finance/CFO 01/10/2015
Director of Finance/CFO 01/08/2014
Director of Finance/CFO 07/09/2011
See the detail of Charles Reinhart's experience

Training of Charles Reinhart

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

78

1st degree connections

13

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies13

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

  1. Stock Market
  2. Insiders
  3. Charles Reinhart
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!